Gallbladder Adenocarcinoma Completed Phase 2 Trials for Gemcitabine (DB00441)

IndicationStatusPhase
DBCOND0031633 (Gallbladder Adenocarcinoma)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00361231Gemcitabine, Oxaliplatin in Combination With Bevacizumab in Biliary Tract and Gallbladder CancerTreatment